A detailed history of Marshall Wace, LLP transactions in Personalis, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 456,976 shares of PSNL stock, worth $1.78 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
456,976
Previous 109,852 315.99%
Holding current value
$1.78 Million
Previous $128,000 1820.31%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.19 - $6.34 $413,077 - $2.2 Million
347,124 Added 315.99%
456,976 $2.46 Million
Q2 2024

Aug 14, 2024

SELL
$1.17 - $1.65 $118,228 - $166,732
-101,050 Reduced 47.91%
109,852 $128,000
Q1 2024

May 15, 2024

BUY
$1.15 - $2.19 $68,104 - $129,693
59,221 Added 39.04%
210,902 $314,000
Q4 2023

Feb 14, 2024

BUY
$0.93 - $2.35 $141,063 - $356,450
151,681 New
151,681 $318,000
Q4 2022

Feb 14, 2023

SELL
$1.78 - $3.64 $383,942 - $785,140
-215,698 Reduced 49.3%
221,823 $439,000
Q3 2022

Nov 14, 2022

SELL
$2.89 - $5.32 $451,189 - $830,563
-156,121 Reduced 26.3%
437,521 $1.3 Million
Q2 2022

Aug 15, 2022

BUY
$3.27 - $8.76 $661,753 - $1.77 Million
202,371 Added 51.72%
593,642 $2.05 Million
Q1 2022

May 16, 2022

SELL
$7.56 - $14.3 $2.8 Million - $5.29 Million
-370,054 Reduced 48.61%
391,271 $3.2 Million
Q4 2021

Feb 14, 2022

SELL
$12.24 - $21.25 $6.5 Million - $11.3 Million
-530,923 Reduced 41.09%
761,325 $10.9 Million
Q3 2021

Nov 15, 2021

SELL
$16.69 - $26.05 $33,029 - $51,552
-1,979 Reduced 0.15%
1,292,248 $24.9 Million
Q2 2021

Aug 13, 2021

BUY
$18.15 - $27.75 $13.5 Million - $20.6 Million
743,691 Added 135.08%
1,294,227 $32.7 Million
Q1 2021

May 17, 2021

BUY
$20.71 - $51.02 $5.19 Million - $12.8 Million
250,604 Added 83.55%
550,536 $13.5 Million
Q4 2020

Feb 16, 2021

BUY
$21.84 - $44.0 $6.55 Million - $13.2 Million
299,932 New
299,932 $11 Million

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $179M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.